Papua New Guinea vs South Sudan: Access to anti-retroviral drugs, female
Papua New Guinea
51.0%
in 2024
South Sudan
51.0%
in 2024
Papua New Guinea rank
118th
South Sudan rank
118th
Access to anti-retroviral drugs, female over time
- Papua New Guinea
- South Sudan
How they compare
Papua New Guinea currently reports 51.0% against 51.0% in South Sudan, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was South Sudan ahead.
Papua New Guinea ranks 118th and South Sudan ranks 118th of 141 countries.
Papua New Guinea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Papua New Guinea | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.8% | 0.1% | 3.7% | Papua New Guinea |
| 2010s | 30.4% | 12.1% | 18.3% | Papua New Guinea |
| 2020s | 46.2% | 40.6% | 5.6% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Papua New Guinea or South Sudan?
- Papua New Guinea, at 51.0% against 51.0% in South Sudan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Papua New Guinea and South Sudan?
- 0.0%, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and South Sudan?
- 25 years are reported by both, from 2000 to 2024.
- How do Papua New Guinea and South Sudan rank globally for access to anti-retroviral drugs, female?
- Papua New Guinea ranks 118th and South Sudan ranks 118th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.